Semaglutide is a GLP-1 receptor agonist researched for its effects on glucose homeostasis and metabolic signaling. In preclinical and clinical models, it has been examined for glycemic control, weight management, and cardiovascular protection in diabetes and obesity simulations, via mechanisms like delayed gastric emptying and enhanced insulin release. It serves as a tool in endocrinology and metabolic research.
For research use only.
